Suven Pharmaceuticals Share Price

Small Cap | Pharmaceuticals and health care | NSE: SUVENPHAR | BSE: 543064

₹1,088.00 image-37.20 (-3.31 %)

Last Updated: 04 Apr 2025 03:59 PM

Technicalsimage BEARISHimage

Overview

Open (₹) 1,126.80

High (₹) 1,135.00

Low (₹) 1,076.50

Prev. Close (₹) 1,125.20

Volume 1,88,950

VWAP (₹) 1,192.59

ROCE (%) 19.24

Industry P/E 44.73

TTM P/E 99.18

P/B Ratio 13.51

Market Cap (₹) Cr.27,696.67

Dividend Yield (%)--

EPS (₹) 11.80

ROE14.65%

Sales Growth (%) -21.56

Profit Growth (%)-26.99

Day Range

1,135.001,135.00

L
H

52 Week Range

597.001,359.00

L
H

Historical Returns

Returns (6M)

-6.25 %

Returns (1Y)

67.85 %

Returns (3Y)

79.21 %

Returns (5Y)

724.24 %

Returns (6M)

-6.25 %

Returns (1Y)

67.85 %

Returns (3Y)

79.21 %

Returns (5Y)

724.24 %

SWOT Analysis

  • Company with Low Debt
  • Book value per share improving over the last 2 years
  • Strong long-term momentum: Price above long-term moving averages (EMA_200)
  • Positive ROC (9) indicates upward momentum.
  • Strong trend indicated by ADX above 25.

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bearish
Bearish

RSI 62.45

MFI 83.71

ATR 78.54

Commodity Channel Index 83.83

ROC125 14.34

ROC21 17.03

Williams %R -37.39

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current1,263.601,312.501,383.151,192.951,144.051,073.401,024.50
Week Ago1,247.241,268.021,303.741,211.521,190.741,155.021,134.24
Month Ago997.741,020.171,051.54966.37943.94912.57890.14

EMA & SMA
info_icon

1088.00

Current Price

EMA & SMApin

Bullish Moving Averages

2

Bearish Moving Averages

18

5 Day 1211.70


9 Day 1166.94


10 Day 1155.33


12 Day 1140.78


14 Day 1143.66

20 Day 1139.73


26 Day 1105.03


50 Day 1116.39


100 Day 1189.11


200 Day 1044.34

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
AMANSA HOLDINGS PRIVATE LIMITEDbulkSell01 Mar, 2024₹689.1931,26,653NSE
ABU DHABI INVESTMENT AUTHORITY STABLEbulkBuy01 Mar, 2024₹698.1515,74,000NSE
RAMBABU CHIRUMAMILLAbulkSell14 Sept, 2023₹530.6838,08,386NSE
ALPHA ALTERNATIVES MSAR LLPbulkSell16 Aug, 2023₹520.0220,91,000NSE
ISHARES INDIA SC MAURITIUS COMPANYblockSell03 Oct, 2022₹450.9527,580NSE
ISHARES CORE EMERGING MARKETS MAURITIUS COblockSell03 Oct, 2022₹450.952,44,540NSE
ISHARES MSCI INDIA SMALL-CAP ETFblockBuy03 Oct, 2022₹450.9527,580NSE
ISHARES CORE MSCI EMERGING MARKETS ETFblockBuy03 Oct, 2022₹450.952,44,540NSE

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
30 Sept, 2023JASTI PROPERTY AND EQUITY HOLDINGS PRIVATE LIMITED in its capacity as sole Trustee of the Jasti Family TrustDisposal₹495.0012,75,37,043NSE
14 Aug, 2023PADMAJA J.A.SDisposal₹501.7728,000NSE
17 Feb, 2023PADMAJA J.A.SDisposal₹482.257,000NSE
02 Sept, 2020PADMAJA J.A.SAcquisition₹640.645,000NSE
31 Aug, 2020PADMAJA J.A.SAcquisition₹688.152,500NSE
27 Aug, 2020PADMAJA J.A.SAcquisition₹702.805,000NSE
24 Aug, 2020PADMAJA J.A.SAcquisition₹685.745,000NSE
04 Jul, 2020PADMA KUMAR RAcquisition₹470.3110,000NSE

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
30 Aug, 2022Rs.5.0000 per share(500%)Special Dividend09 Sept, 202212 Sept, 2022
29 Aug, 2022Rs.1.0000 per share(100%)Interim Dividend09 Sept, 202212 Sept, 2022
03 May, 2022Rs.1.0000 per share(100%)Special Dividend13 May, 202217 May, 2022
17 Aug, 2020Bonus issue in the ratio of 1:1 of Re. 1/-.25 Sept, 202028 Sept, 2020

Announcements

DateSourceDetail
02 Apr, 2025NSE IndiaSuven Pharmaceuticals Limited has informed the Exchange about General Updates
01 Apr, 2025NSE IndiaSuven Pharmaceuticals Limited has informed the Exchange about General Updates
01 Apr, 2025BSE IndiaCautionary email received from the stock exchange
28 Mar, 2025NSE IndiaSUVEN PHARMACEUTICALS LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
28 Mar, 2025NSE IndiaSuven Pharmaceuticals Limited has informed the Exchange regarding Resignation of Mr Subba Raju Komaravolu as Senior Management Personnel of the company w.e.f. closing of working hours on March 31, 2025.
28 Mar, 2025BSE IndiaResignation of Senior Management Personnel
27 Mar, 2025NSE IndiaSuven Pharmaceuticals Limited has informed the Exchange regarding ''Update on merger''.
27 Mar, 2025BSE IndiaUpdate on Merger
27 Mar, 2025NSE IndiaSUVEN PHARMACEUTICALS LIMITED has informed the Exchange about Closure of Trading Window
27 Mar, 2025NSE IndiaSUVEN PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 28-May-2025 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2025 .

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Audited Results--28 Mar, 202528 May, 2025
Quarterly Results--28 Dec, 202412 Feb, 2025
Quarterly Results--01 Oct, 202412 Nov, 2024
Quarterly Results--05 Aug, 202409 Aug, 2024
Audited Results(Revised)22 May, 202430 May, 2024
Quarterly Results--22 May, 202405 Feb, 2024
Quarterly Results--03 Nov, 202309 Nov, 2023
Quarterly Results--03 Aug, 202308 Aug, 2023
Audited Results--19 May, 202325 May, 2023
Quarterly Results--31 Jan, 202306 Feb, 2023

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Dec, 2023Dec, 2022Dec, 2021Dec, 2020
Promoter Group50.1%60%60%60%60%
Foreign Institutions +10.84%10.14%8.11%8.25%6.04%
Domestic Institutions +16.67%15.94%11.36%5.93%4.65%
Government0.01%0.01%0%0%0%
Public22.38%13.91%20.53%25.82%29.31%
Others0%0%0%0%0%

About Suven Pharmaceuticals

Suven Pharmaceuticals is a Public Limited Listed company incorporated on 06/11/2018 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24299MH2018PLC422236 and registration number is 422236. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1024.99 Cr. and Equity Capital is Rs. 25.46 Cr. for the Year ended 31/03/2024.

Parent Organisation

Not Applicable

Founded

2018

Managing Director

Dr. V Prasada Raju

NSE Symbol

SUVENPHAR

Suven Pharmaceuticals Management

NameDesignation
Mr. Annaswamy VaidheeshExecutive Chairperson
Dr. V Prasada RajuManaging Director
Mr. Pankaj PatwariNon Executive Director
Ms. Shweta JalanNon Executive Director
Ms. Matangi GowrishankarIndependent Director
Mr. Vinod RaoIndependent Director
Mr. K G AnanthakrishnanIndependent Director
Mr. Pravin Rao Udhyavara BhadyaIndependent Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Sun Pharmaceutical Industries₹4,10,130.32₹1,709.35 image
₹1,770.00(-3.43%)
₹1,376.750 - ₹1,960.200
Divi's Laboratories₹1,45,552.44₹5,482.85 image
₹5,763.00(-4.86%)
₹3,613.550 - ₹6,448.750
Cipla₹1,14,298.01₹1,415.25 image
₹1,495.70(-5.38%)
₹1,317.600 - ₹1,702.000
Torrent Pharmaceuticals₹1,11,230.09₹3,286.50 image
₹3,247.70(1.19%)
₹2,508.650 - ₹3,589.950
Mankind Pharma₹1,01,131.25₹2,451.20 image
₹2,427.70(0.97%)
₹1,910.100 - ₹3,050.000

FAQs on Suven Pharmaceuticals

What is the share price of Suven Pharmaceuticals?

The share price of Suven Pharmaceuticals on 04 Apr, 2025 is ₹ 1,088.00.

What is 52W high and 52W low share price of Suven Pharmaceuticals?

The highest and lowest 52W share prices of Suven Pharmaceuticals are ₹ 1359.000 and ₹ 597.000

What is the market cap of Suven Pharmaceuticals?

The market capitalization of Suven Pharmaceuticals as of 04 Apr, 2025 is ₹ 27,696.67 Crores

What is the P/E ratio of Suven Pharmaceuticals?

The current P/E ratio of Suven Pharmaceuticals as of 04 Apr, 2025 is 44.73

What is the PB ratio of Suven Pharmaceuticals?

The PB ratio of Suven Pharmaceuticals as of 04 Apr, 2025 is 13.51

Top Gainers

₹18.07image

₹15.14 (0.19%)

₹66.60image

₹57.80 (0.15%)

₹88.74image

₹73.95 (0.20%)

₹197.50image

₹167.35 (0.18%)

Top Losers

₹307.35image

₹368.55 (-0.17%)

₹108.20image

₹127.00 (-0.15%)

₹0.54image

₹1.03 (-0.48%)

₹2,705.55image

₹3,206.90 (-0.16%)

Market Indices

Sensex

₹75,364.69image

₹76,295.36 (-0.01%)

Source : Dion Global Solutions Limited